Archer Daniels Midland Company (ADM) is set to invest approximately $300 million to expand its alternative protein production capabilities, reinforcing its growth in the Nutrition segment. As the company prepares to report its first-quarter 2022 results, analysts project earnings per share of $1.33, a decline from the previous year, but ADM has maintained a strong performance, consistently exceeding Zacks Consensus Estimates. With shares up 50.2% and a Zacks Rank of #1 (Strong Buy), ADM is poised for over 15% growth in operating profit this year, despite facing some cost pressures.